Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 4 minute read Pharma Industry News AbbVie to develop amylin analog for obesity treatment in $350m licensing deal with Gubra AbbVie has taken a significant step into obesity treatment through a licensing agreement with Denmark-based Gubra, a company… byPallavi MadhirajuMarch 3, 2025